| Clinical outcome and pathological features associated with NRAS mutation in cutaneous melanoma B Devitt, W Liu, R Salemi, R Wolfe, J Kelly, CY Tzen, A Dobrovic, ... Pigment cell & melanoma research 24 (4), 666-672, 2011 | 299 | 2011 |
| Team dynamics, decision making, and attitudes toward multidisciplinary cancer meetings: health professionals' perspectives B Devitt, J Philip, SA McLachlan Journal of oncology practice 6 (6), e17-e20, 2010 | 127 | 2010 |
| The role of BRAF mutations in primary melanoma growth rate and survival VJ Mar, W Liu, B Devitt, SQ Wong, A Dobrovic, GA McArthur, R Wolfe, ... British Journal of Dermatology 173 (1), 76-82, 2015 | 46 | 2015 |
| What should a support program for people with lung cancer look like? Differing attitudes of patients and support group facilitators B Devitt, A Hatton, C Baravelli, P Schofield, M Jefford, L Mileshkin Journal of Thoracic Oncology 5 (8), 1227-1232, 2010 | 34 | 2010 |
| Utilisation of geriatric assessment in oncology-a survey of Australian medical oncologists THM To, WK Soo, H Lane, A Khattak, C Steer, B Devitt, HM Dhillon, ... Journal of geriatric oncology 10 (2), 216-221, 2019 | 30 | 2019 |
| Comprehensive geriatric assessment is useful in an elderly Australian population with diffuse large B‐cell lymphoma receiving rituximab‐chemotherapy combinations DM Ong, M Ashby, A Grigg, G Gard, ZY Ng, H Huang, YS Chong, ... British journal of haematology 187 (1), 73-81, 2019 | 27 | 2019 |
| The Elderly Functional Index (ELFI), a patient-reported outcome measure of functional status in patients with cancer: a multicentre, prospective validation study WK Soo, M King, A Pope, C Steer, B Devitt, S Chua, P Parente, ID Davis, ... The Lancet Healthy Longevity 2 (1), e24-e33, 2021 | 18 | 2021 |
| Use of ibandronate in the prevention of skeletal events in metastatic breast cancer B Devitt, SA McLachlan Therapeutics and Clinical Risk Management 4 (2), 453-458, 2008 | 16 | 2008 |
| Re: Tumor boards and the quality of cancer care B Devitt, J Philip, SA McLachlan Journal of the National Cancer Institute 105 (23), 1838-1838, 2013 | 15 | 2013 |
| Addition of endocrine therapy to dual anti-HER2 targeted therapy in initial treatment of HER2+/HR+ metastatic breast cancer M Loft, SW Lok, R De Boer, L Malik, S Greenberg, B Yeo, A Anton, ... Breast Cancer Research and Treatment 198 (1), 67-74, 2023 | 10 | 2023 |
| Abstract P3-09-04: Phase 2, open-label study of intratumoral tavokinogene telseplasmid (tavo) plus electroporation in combination with intravenous pembrolizumab therapy in … ML Telli, I Wapnir, B Devitt, K Cuff, H Soliman, S Vinayak, DA Canton, ... Cancer Research 80 (4_Supplement), P3-09-04-P3-09-04, 2020 | 9* | 2020 |
| A Window Study of Acalabrutinib & Rituximab, Followed By Chemotherapy & Autograft (ASCT) in Fit Patients with Treatment Naïve Mantle Cell Lymphoma (MCL): First Report of the … EA Hawkes, ST Lee, L Churilov, T Armytage, G Hodges, CY Cheah, ... Blood 142, 735, 2023 | 5 | 2023 |
| Understanding patients’ attitudes toward cancer multidisciplinary meetings: a mixed methods study B Devitt, J Philip, M Singh, SA McLachlan Journal of Oncology Practice 16 (2), e175-e182, 2020 | 5 | 2020 |
| Clinical outcome and pathologic features associated with NRAS mutation in cutaneous melanoma. BA Devitt, W Liu, R Salemi, R Wolfe, J Kelly, A Dobrovic, GA McArthur Journal of Clinical Oncology 28 (15_suppl), 8500-8500, 2010 | 5 | 2010 |
| Is geriatric assessment being incorporated into general oncology? T To, B Devitt, H Lane Journal of Geriatric Oncology 5 (2), 219-220, 2014 | 4 | 2014 |
| Real‐world impact of anti‐HER2 therapy‐related cardiotoxicity in patients with advanced HER2‐positive breast cancer C Conduit, RH de Boer, S Lok, P Gibbs, L Malik, Z Loh, B Yeo, ... Asia‐Pacific Journal of Clinical Oncology 16 (6), 356-362, 2020 | 3 | 2020 |
| ELderly Functional Index (ELFI): Validation of a self-reported measure of functional status in cancer patients. WK Soo, M King, A Pope, CB Steer, BA Devitt, SLL Chua, P Parente, ... Journal of Clinical Oncology 38 (15_suppl), e19126-e19126, 2020 | 3 | 2020 |
| Pertuzumab study in the neoadjuvant setting for HER2‐positive nonmetastatic breast cancer in Australia (PeRSIA) SW Lok, R De Boer, S Baron‐Hay, P Button, B Devitt, BC Forster, P Fox, ... International Journal of Cancer 152 (2), 267-275, 2023 | 2 | 2023 |
| Abstract OT2-01-03: Trial in progress: Phase 2 study of intratumoral plasmid interleukin-12 (tavokinogene telseplasmid; TAVO™) plus electroporation in combination with … M Telli, B Devitt, K Cuff, S Vinayak, R Nanda, AJ Montero, R Hui, ... Cancer Research 82 (4_Supplement), OT2-01-03-OT2-01-03, 2022 | 2 | 2022 |
| Abstract P1-17-06: Long-term incidence of taxane induced peripheral neuropathy in early breast cancer patients, a real world, single centre experience exploring effects on … EF Blackley, MG Kesper, P Savas, B Devitt Cancer Research 80 (4_Supplement), P1-17-06-P1-17-06, 2020 | 2 | 2020 |
